» Download Public Reports
32 reports
- Company report
- March 2011
- 3 pages
... radiopharmaceuticals, to create images of organs and lesions and to treat various diseases, like cancer. The technique works by injecting into the patient S body targeted radiopharmaceuticals that accumulate ...
March 2011
... immunoassay tests including tetanus quick stick (tqs), for asng tetanus immunity. Ingen is developing bji inoplex, a novel test to detect infections associated with prosthetic joints. Financials ...
March 2011
... Business in north america * excluding the impact of the end of the nhls contract in south africa triangle45right strong increase in biom rieux S market share 2011 microbiology market share growing leadership ...
April 2011
... Pathologies such as cardiovascular disorders, cancer or central nervous system diseases by themselves account for 25 million exams. Number of exams (in millions) x-ray mri nuclear medicine total oncology 8.4 2 ...
May 2011
... Merieux immunoassay business unit, will be critical in making bg medicine's fda-cleared galectin-3 test and amipredict cardiovascular diagnostic test that was recently submitted to the fda, the standards of care. I ...
November 2012
... Distributor of in-vitro diagnostics in the french market (1) Creation of a french fully integrated leader in the in-vitro diagnostic field, involved from research to commercialization of specialty ...
December 2011
... As the in vitro diagnostics industry develops, more and more patent applications are filed and patents granted, leading to an increased risk of unintentional infringement of third-party patents. In general, patent ...
November 2011
... Be controlled most effectively if diagnostics is introduced at an early stage of disease development. Information resulting from molecular diagnostics could be used to make more rational deci- sions about ...
April 2011
... Food water and environmental microbiology sampling and the health protection agency - rob johnston health protection agency health protection agency - services health ...
» Purchase Premium Reports
(From $ 300 - $ 12 800)
About 700 reports
- $ 12 800
- Industry report
- February 2013
- by Venture Planning Group
This new 500-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities ...
February 2013
$ 12 800
This new 450-page five-country study from Venture Planning Group presents test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of ...
February 2013
$ 12 800
This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...
February 2013
$ 12 800
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging ...
February 2013
$ 12 800
This new 1,600-page five-country report from Venture Planning Group is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ...
February 2013
$ 12 800
This new 600-page five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European blood ...
February 2013
$ 12 800
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities ...
